tm logo
EYREVEV
Live/Pending
PUBLISHED FOR OPPOSITION

on 23 Apr 2024

Last Applicant/ Owned by

One Amgen Center rive

Thousand Oaks

US

913201799

Serial Number

98191443 filed on 21st Sep 2023

Registration Number

N/A

Correspondent Address

ELSA . LEMOINEAMGEN INC.

ONE AMGEN CENTER RIVETRAEMARK OPERATIONS-MS-28-5A

THOUSAN OAKS,CA

91320-1799

UNITE STATES

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

EYREVEV

pharmaceutical preparations and substances for use in the treatment of hematological, immune, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmRead More

Classification Information


Class [005]
Pharmaceutical Products


pharmaceutical preparations and substances for use in the treatment of hematological, immune, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure

Mark Details


Serial Number

No 98191443

Mark Type

No Service/Collective Mark

Attorney Docket Number

No TM-2267-US-1

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Status DateAction Taken
23rd Apr 2024OICIAL GAZETTE PUBLICATION CONIRMATION E-MAILE
23rd Apr 2024PUBLISHE OR OPPOSITION
03rd Apr 2024NOTIICATION O NOTICE O PUBLICATION E-MAILE
21st Mar 2024APPROVE OR PUB - PRINCIPAL REGISTER
21st Mar 2024ASSIGNE TO EXAMINER
08th Oct 2023NEW APPLICATION OICE SUPPLIE ATA ENTERE
25th Sep 2023NEW APPLICATION ENTERE